41. Corrigendum to 'Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)' [European Journal of Cancer 152 (2021) 116-128]. (January 2022) Authors: Gogas, Helen; Dummer, Reinhard; Ascierto, Paolo A.; Arance, Ana; Mandalà, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsová, Ivana; Gutzmer, Ralf; Chiarion Sileni, Vanna; Dutriaux, Caroline; Yamazaki, Naoya; Loquai, Carmen; Queirolo, Paola; de Willem, Groot J.; Sellier, Abir T.... Journal: European journal of cancer Issue: Volume 160(2022) Page Start: 287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. Current diagnosis and treatment of basal cell carcinoma. (September 2015) Authors: Alter, Mareike; Hillen, Uwe; Leiter, Ulrike; Sachse, Michael; Gutzmer, Ralf Journal: Journal der Deutschen Dermatologischen Gesellschaft Issue: Volume 13:Number 9(2015) Page Start: 863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha‐2b in metastatic melanoma (phase II DeCOG trial). (23rd July 2013) Authors: Degen, Annette; Weichenthal, Michael; Ugurel, Selma; Trefzer, Uwe; Kilian, Katharina; Garbe, Claus; Egberts, Friederike; Poppe, Lìdia Marilia; Hauschild, Axel; Gutzmer, Ralf Journal: Journal der Deutschen Dermatologischen Gesellschaft Issue: Volume 11:Number 9(2013) Page Start: 846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy. (June 2016) Authors: Hofmann, Lars; Forschner, Andrea; Loquai, Carmen; Goldinger, Simone M.; Zimmer, Lisa; Ugurel, Selma; Schmidgen, Maria I.; Gutzmer, Ralf; Utikal, Jochen S.; Göppner, Daniela; Hassel, Jessica C.; Meier, Friedegund; Tietze, Julia K.; Thomas, Ioannis; Weishaupt, Carsten; Leverkus, Martin; Wahl, Renat... Journal: European journal of cancer Issue: Volume 60(2016) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. Diagnosis and Differential Diagnosis of Neurological Adverse Events during Immune Checkpoint Inhibitor Therapy. (7th December 2020) Authors: Möhn, Nora; Mahjoub, Susann; Gutzmer, Ralf; Satzger, Imke; Beutel, Gernot; Ivanyi, Philipp; Golpon, Heiko; Wattjes, Mike P.; Stangel, Martin; Skripuletz, Thomas Other Names: Coppola Vincenzo Academic Editor. Journal: Journal of oncology Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy. (April 2016) Authors: Eigentler, Thomas K.; Hassel, Jessica C.; Berking, Carola; Aberle, Jens; Bachmann, Oliver; Grünwald, Viktor; Kähler, Katharina C.; Loquai, Carmen; Reinmuth, Niels; Steins, Martin; Zimmer, Lisa; Sendl, Anna; Gutzmer, Ralf Journal: Cancer treatment reviews Issue: Volume 45(2016) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
47. Die Entwicklung der Therapie des Hautkrebses geht weiter – Bericht von der Jahrestagung der American Society of Clinical Oncology (ASCO) in Chicago vom 31.5.– 3.6. 2018. (5th August 2018) Authors: Gutzmer, Ralf Journal: Journal der Deutschen Dermatologischen Gesellschaft Issue: Volume 16:Number 8(2018) Page Start: 1063 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
48. Die Entwicklung der Therapie des Melanoms geht weiter – Berichte von den Jahrestagungen ESMO und SMR im Oktober/November 2016. (March 2017) Authors: Gutzmer, Ralf; Höller, Christoph Journal: Journal der Deutschen Dermatologischen Gesellschaft Issue: Volume 15:Number 3(2017) Page Start: 350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
49. Effects of mammalian target of rapamycin inhibitors on cytokine production and differentiation in keratinocytes. Issue 10 (October 2016) Authors: DeTemple, Viola; Satzger, Imke; Walter, Antje; Schaper, Katrin; Gutzmer, Ralf Journal: Experimental dermatology Issue: Volume 25:Issue 10(2016) Page Start: 775 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
50. Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial. Issue 5 (May 2018) Authors: Dummer, Reinhard; Ascierto, Paolo A; Gogas, Helen J; Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion-Sileni, Vanna; Dutriaux, Caroline; de Groot, Jan Willem B; Yamazaki, Naoya; Loquai, Carmen; Moutouh-de Parseval, Laure A;... Journal: Lancet oncology Issue: Volume 19:Issue 5(2018) Page Start: 603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗